Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.

Saved in:
Bibliographic Details
Title: Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Authors: Rudolph A; Working Group on Cardiovascular Magnetic Resonance, Experimental Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany; HELIOS Klinikum Berlin-Buch, Department of Cardiology and Nephrology, Berlin, Germany., von Knobelsdorff-Brenkenhoff F, Wassmuth R, Prothmann M, Utz W, Schulz-Menger J
Source: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2014 May; Vol. 39 (5), pp. 1153-60. Date of Electronic Publication: 2013 Oct 22.
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1522-2586
DOI:10.1002/jmri.24264